RS54162B1 - Pharmaceutical composition based on the medicinal herbs for use in human and veterinary medicine - Google Patents
Pharmaceutical composition based on the medicinal herbs for use in human and veterinary medicineInfo
- Publication number
- RS54162B1 RS54162B1 RS20110586A RSP20110586A RS54162B1 RS 54162 B1 RS54162 B1 RS 54162B1 RS 20110586 A RS20110586 A RS 20110586A RS P20110586 A RSP20110586 A RS P20110586A RS 54162 B1 RS54162 B1 RS 54162B1
- Authority
- RS
- Serbia
- Prior art keywords
- human
- lamiaceae
- pharmaceutical composition
- composition based
- veterinary medicine
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/09—Lichens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/12—Mucolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medical Informatics (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Pulmonology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
Farmaceutska kompozicija na bazi lekovitog bilja, naznačena time, da se sastoji od biljnih ekstrakata lišaja jevrejske brade (Usnea barbata L., Parmeliaceae), herbe origana (Origanum heracleoticum L., Lamiaceae), i/ili herbe šarplaninskog čaja (Sideritis scardica Griseb., Lamiaceae), i/ili herbe planinskog čubra (Satureja montana L., Lamiaceae) za izradu farmaceutskih proizvoda u polučvrstom ili tečnom obliku kod zapaljenja sluznice usne duplje i ždrela u humanoj i vetreinarskoj medicini. Prijava sadrži još 6 zavisnih patentnih zahteva.Pharmaceutical composition based on medicinal herbs, characterized in that it consists of herbal extracts of lichen beard (Usnea barbata L., Parmeliaceae), oregano herb (Origanum heracleoticum L., Lamiaceae), and / or sharplanin tea herb (Sideritis scardica Gris. , Lamiaceae), and / or mountain savory herb (Satureja montana L., Lamiaceae) for the manufacture of pharmaceutical products in semi - solid or liquid form for inflammation of the mucous membranes of the oral cavity and pharynx in human and veterinary medicine. The application contains 6 more dependent patent claims.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RS20110586A RS54162B1 (en) | 2011-12-28 | 2011-12-28 | Pharmaceutical composition based on the medicinal herbs for use in human and veterinary medicine |
PCT/RS2012/000017 WO2013100774A1 (en) | 2011-12-28 | 2012-12-26 | Pharmaceutical compositions containing herbal based active ingredients for application in human and veterinary medicine |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RS20110586A RS54162B1 (en) | 2011-12-28 | 2011-12-28 | Pharmaceutical composition based on the medicinal herbs for use in human and veterinary medicine |
Publications (2)
Publication Number | Publication Date |
---|---|
RS20110586A1 RS20110586A1 (en) | 2013-08-30 |
RS54162B1 true RS54162B1 (en) | 2015-12-31 |
Family
ID=47891884
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RS20110586A RS54162B1 (en) | 2011-12-28 | 2011-12-28 | Pharmaceutical composition based on the medicinal herbs for use in human and veterinary medicine |
Country Status (2)
Country | Link |
---|---|
RS (1) | RS54162B1 (en) |
WO (1) | WO2013100774A1 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CL2018003878A1 (en) * | 2018-12-28 | 2019-05-17 | Univ De Santiago De Chile 50% | Formulation comprising extract of crynodendron patagua and essential oil of satureja montana for the prevention and treatment of diseases caused by piscirickettsia salmonis in individuals of the genus Salmo. |
CN113876645B (en) * | 2020-07-01 | 2024-01-05 | 伽蓝(集团)股份有限公司 | Usnea barbata extract, application thereof and skin external preparation containing same |
JP2023551599A (en) * | 2020-10-16 | 2023-12-08 | ハーブエリクサ ドゥオオ スレムスカ カメニツァ | Herbal drug preparations for the prevention and treatment of Helicobacter pylori infection |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2354517A1 (en) | 1973-10-31 | 1975-05-28 | Handelsgesellschaft Schlosser | Skin cosmetics e.g. deodorant sprays - contg. lichen acids, pref. usnic or evernic acids, dissolved in alcohols with hydroxy-amines |
IT1204901B (en) | 1986-06-25 | 1989-03-10 | Iscofar Sas | COMPOSITIONS CONTAINING USNIC ACID OR ITS DERIVATIVES SUITABLE FOR USE IN THE TREATMENT OF TOOTH DECAY |
ES2252956T3 (en) | 1998-07-13 | 2006-05-16 | Joerg Peter Schuer | ANTIMICROBIAL COMPOSITION. |
EP1591125A1 (en) * | 2004-04-19 | 2005-11-02 | Universitätsklinikum Freiburg | Pharmaceutical composition comprising extracts of lichens and hypericum |
US8119169B2 (en) * | 2004-12-28 | 2012-02-21 | Colgate-Palmolive Company | Oregano oral care compositions and methods of use thereof |
-
2011
- 2011-12-28 RS RS20110586A patent/RS54162B1/en unknown
-
2012
- 2012-12-26 WO PCT/RS2012/000017 patent/WO2013100774A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2013100774A1 (en) | 2013-07-04 |
RS20110586A1 (en) | 2013-08-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NZ731248A (en) | Cannabis extracts and methods of preparing and using same | |
CL2016002955A1 (en) | Sweetener composition comprising allulose and a stevia extract; food product or beverage comprising the sweetener composition; tabletop sweetener; use of the sweetener composition. | |
BR112018007560A2 (en) | cosmetic composition having probiotic bacteria | |
CO2021013677A2 (en) | Process for the manufacture of stable bacterial extracts and their use as drugs | |
RS54162B1 (en) | Pharmaceutical composition based on the medicinal herbs for use in human and veterinary medicine | |
CN106852907A (en) | A kind of production method of soluble lyophilized film and products thereof | |
AR100425A1 (en) | COMPOSITION IN THE FORM OF COMPACTED PARTICLES | |
AR108233A1 (en) | ORIC PHARMACEUTICAL COMPOSITIONS OF NICOTINAMIDE | |
RU2015137043A (en) | LIQUID MENTAL-CONTAINING COMPOSITIONS | |
EA201791526A1 (en) | NATURAL COMPOSITION OF A SWEEPER FROM LO KHAN GO | |
AR117509A1 (en) | STEVIA PLANT WITH HIGH BROUSSONETIN CONTENT | |
AR101673A1 (en) | COMPOSITION FOR THE TREATMENT OF NEUROPATHIES AND NEUROPATHIC PAIN | |
CN103891961B (en) | Snow chrysanthemum Herba Schizonepetae tea | |
BR112019024814A2 (en) | granule formulation, method for preparing a granule formulation, and, edible composition, pharmaceutical composition, nutraceutical composition, chewing gum or toothpaste | |
EA201600223A1 (en) | MEANS FOR PREVENTION AND TREATMENT OF INFECTIOUS-INFLAMMATORY DISEASES OF THE THROAT / THROAT AND THE MORAL CAVITY ON THE BASIS OF MEDICINAL PLANTS | |
CN106560096A (en) | Delivery and dissolving device of lyophilized excipient preparation | |
CL2014000406A1 (en) | Procedure for the production of dried plant extracts comprising rumicis herba, verbena officinalis, sambucus nigra, primula veris and gentiana lutea; pharmaceutical preparations containing plant extracts; nutritional supplement | |
HRP20140998T1 (en) | Conglutin-gamma as medicament and diet supplement | |
Pereira et al. | Phenolic compounds among the bioactive molecules in Ginkgo biloba L. | |
UA120292U (en) | METHOD OF PREPARATION OF DRY MILK AND CHICORIC DRINK "CYCOROLACT SOFT WITH Cocoa" | |
Poveda | Expression and localization of aqua-glyceroporins AQP3 and AQP9 in rat oral mucosa. | |
南條俊文 | Development of a method to measure Aβ42 in nasal cavity samples and its application in normal human volunteers. | |
TR201714725A1 (en) | DRY POWDER FORMULATION WITH BETA-2 AGONIST AND ANTICOLINERGIC | |
TR201714893A1 (en) | Dry powder composition containing Beta-2 Agonist and Corticosteroid. | |
UA130275U (en) | SYRUP FOR THE TREATMENT AND PREVENTION OF RESPIRATORY DISEASES |